Riot Platforms Surges to New 52Week High Tapping 2593
Tulsi Gabbard Steps Down as Intelligence Chief to Focus on Family Health
Potential SpaceX IPO Could Join Historys Largest Stock Market Debuts
Singapore Core Inflation Sees Surprise Drop in April but Looming Energy Costs Pose Risks
Elon Musks Legal Setback Against OpenAI Why the Litigation Strategy May Continue
GitHub Outages and Rival Tools Challenge Microsofts AI Coding Ambitions
EZRA Q1 2023 Earnings Massive EPS Surprise of 324 Against Negative Estimate Revenue Unreported
Nuburu Inc BURU Q3 2023 Earnings Net Loss Reported as Company Advances Industrial Laser Commercialization
ACXP Q1 2026 Earnings Narrowed Loss Surprises as Acurx Advances Lead Candidate
SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue
Liberty Live Holdings Inc Series A LLYVA Q4 2025 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower
United Parks Resorts PRKS Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment
PDF Solutions Surges 339 as Shares Approach Key Resistance Level
SPACSphere Acquisition Corp SSAC Holds Steady at 995 Testing Key Technical Juncture
Daedalus Special Acquisition Corp Warrants DSACW Remain Flat at 045 as Market Awaits Catalysts
Community Health Systems CYH Faces Renewed Selling Pressure Tests Key Support
Genius Sports GENI Edges Higher as Stock Holds Above Key Support
Scienture Holdings Inc SCNX Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline and Operational Progress
ANIP Q1 2026 Earnings EPS Surges 54 Above Estimates Driving Strong Performance
Nutriband NTRB Q1 2026 Earnings Large EPS Beat on Minimal Loss vs Deeply Negative Consensus
BNED Q4 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally
TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher
Coeur Mining Q1 2026 Earnings EPS Misses Expectations Stock Slightly Negative
Nifty 50 Sensex Likely to Open Lower on May 27 as Gift Nifty Signals Weakness
GLDG Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline in PreRevenue Stage
Fractyl Health GUTS Dips Near Key Support After 662 Decline Biotech Volatility Continues